Isolated flavonoids against mammary tumour cells LM2

Zeitschrift fur Naturforschung - Section C Journal of Biosciences

Volumn 64, Issue 1-2, 2009, Pages 32-36

  Carli, Camila B De A ^a   De Matos, Djamile C ^a   Lopes, Flávia C M ^a   Maia, Danielle C G ^a   Dias, Maristela B ^a   Sannomiya, Miriam ^a   Rodrigues, Clenilson M ^a   Andreo, Marcio A ^a   Vilegas, Wagner ^a   Colombo, Lucas L ^b   Carlos, Iracilda Z ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Antitumour activity; Cytokine; Flavonoids

Indexed keywords

BYRSONIMA CRASSA; DAVILLA; MOURIRI; MURINAE; PUSA;

EID: 62549140614     PISSN: 09395075     EISSN: None     Source Type: Journal    
DOI: 10.1515/znc-2009-1-206     Document Type: Article

References (18)

1. Andreo M. A., Ballesteros K. V., Hiruma-Lima C. A., Machado De Rocha L. R., Souza Brito A. R., and Vilegas W. (2006), Effect of Mouriri pusa extracts on experimentally induced gastric lesions in rodents: Role of endogenous sulfhydryls compounds and nitric oxide in gastroprotection. J. Ethnopharmacol. 107, 431-441.
2. Cragg G. M., Boyd M. R., Cardellina J. H., Newman D. J., Snader K. M., and McCloud T. G. (1994), Ethnobotany and drug discovery: the experience of the US National Cancer Institute. In: Ethnobotany and Search for New Drugs. Ciba Foundation Symposium 185. Wiley, Chichester, pp. 178-196.
3. Duthie S. J. and Dobson V. L. (1999), Dietary flavonoids protect human colonocyte DNA from oxidative attack in vitro. Eur. J. Nutr. 38, 28-34.
4. Gelin J., Moldawer L. L., Lonnroth C., Sherry B., Chizzonite R., and Lundholm K. (1991), Role of endogenous tumour necrosis factor-α and interleukin-1 for experimental tumour growth and the development of cancer cachexia. Cancer Res. 51, 415-421.
5. 15N] nitrate in biological fluids. Anal. Biochem. 126, 131-138.
6. Hegyesi H., Tóth S., Molnár V., Fülöp K. A., and Falus A. (2007), Endogenous and exogenous histamine influences on angiogenesis related gene expression of mice mammary adenocarcinoma. Inflamm. Res. 56, 37-38.
7. Hofseth L. J., Hussain P., Wogan G. N., and Harris C. C. (2003), Nitric oxide in cancer and chemoprevention. Free Radical Biol. Med. 34, 955-968.
8. Jadeski L. C. and Lala P. K. (1999), Nitric oxide synthase inhibition by NG-nitro-L-arginine methyl ester inhibits tumour-induced angiogenesis in mammary tumours. Am. J. Pathol. 155, 1381-1390.
9. Keil D. E., Luebke R. W., and Pruett B. S. (1999), Differences in the effects of dexamethasone on macrophage nitrite production: dependence on exposure regime (in vivo or in vitro) and activation stimuli. Int. J. Immunopharmacol. 17, 157-166.
10. Kovalovsky D., Refojo D., Holsboer F., and Arzt E. (2000), Molecular mechanisms and Th1/Th2 pathways in corticosteroid regulation of cytokine production. J. Neuroimmunol. 109, 23-29.
11. Liew F. Y. (1995), Interactions between cytokines and nitric oxide. Adv. Neuroimmunol. 5, 201-209.
12. Mosmann T. (1983), Rapid colorimetric assay for cellular growth and survival: application and cytotoxicity assays. J. Immunol. Methods 65, 55-63.
13. Pomilio A. B., Sola G. A. R., Mayer A. M. S., and Rumi L. S. (1994), Antitumour and cytotoxic screen of 5,6,7-trisubstituted flavones from Gomphrena martiana. J. Ethnopharmacol. 44, 25-33.
14. Rinaldo D., Silva M. A., Rodrigues C. M., Calvo T. R., Sannomiya M., Santos L. C., and Vilegas W. (2006), Preparative separation of flavonoids from the medicinal plant D. elliptica St. Hill. by high-speed countercurrent chromatography. Quim. Nova 29, 947.
15. Sannomiya M., Rodrigues C. M., Coelho R. G., Dos Santos L. C., Hiruma-Lima C. A., Brito A. R. S., and Vilegas W. (2004), Application of preparative high-speed counter-current chromatography for the separation of flavonoids from the leaves of Byrsonima crassa Niedenzu (IK). J. Chromatogr. A 1035, 47-51.
16. Santos F. V., Colus I. M., Silva M. A., Vilegas W., and Varanda E. A. (2006), Assessment of DNA damage by extracts and fractions of Strychnos pseudoquina, a Brazilian medicinal plant with antiulcerogenic activity. Food Chem. Toxicol. 44, 1585-1589.
17. Xie K. and Fidler I. J. (1998), Therapy of cancer metastasis by activation of the inducible nitric oxide synthase. Cancer Metastasis Rev. 17, 55-75.
18. Yan L., Anderson G. M., Dewitte M., and Nakada M. T. (2006), Therapeutic potential of cytokine and chemokine antagonists in cancer therapy. Eur. J. Cancer 42, 793-802.